跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mepresone 40 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Mepresone 40
Approved
STANDARD
Mepresone 40
Lyka Labs Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7aab78525efa3452
Company
Lyka Labs Ltd.
Type
Standard
Approval Details
Approval Id
7aab78525efa3452
Drug Approval Philippines Name
Mepresone 40
Product Name
Mepresone 40
Registration Number
DRP-6110-04
Brand Name
Mepresone 40
Generic Name
Methylprednisolone (as sodium succinate)
Dosage Form
Powder for Solution for Injection (I.V./I.M.)
Dosage Strength
40 mg
Manufacturer
Lyka Labs Ltd.
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
29 June 2024
Expiry Date
16 April 2030
Pharmacologic Category
Corticosteroid
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7aab78525efa3452
Type
Standard
Back to Philippines FDA Approvals